Cyteir
is a Massachusetts-based biotechnology company that develops and commercializes therapeutics for the treatment of cancer... Read moreCyteir
is a Massachusetts-based biotechnology company that develops and commercializes therapeutics for the treatment of cancer... Read more
News
Mar 27, 2024
Owler
Cyteir Therapeutics, Inc.: Cyteir's revenue changed from $14.84B in Sep 2023 to $14.56B in Dec 2023
Mar 07, 2024
StreetInsider
Press Release: Cyteir : Cyteir Announces Timeline for Voluntarily Delisting from Nasdaq
Nov 06, 2023
Marketscreener
Cyteir: Cyteir Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Oct 12, 2023
Nasdaq
Cyteir: Cyteir : Results From Dose Expansion Cohort Of CYT-0851 In Ovarian Cancer Show Promising Activity
Aug 07, 2023
Marketscreener
Cyteir: Cyteir Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Jun 30, 2023
Endpoints News
Cyteir: Oncology biotech Cyteir to dissolve two years after IPO
Jun 30, 2023
Nasdaq
Cyteir: Cyteir Therapeutics To Discontinue CYT-0851 Development Program, Dissolve Company
Jun 03, 2023
MarketScreener
Cyteir: Preliminary Ongoing Results with CYT-0851 in Combination with Capecitabine or Gemcitabine in Advanced Solid Tumors Show Early Clinical Activity and Generally Well Tolerated Safety Profile
May 12, 2023
Endpoints News
Cyteir: Fusion and Cyteir refocus pipelines; Nona Biosciences collaborating with PharmaEssentia
May 10, 2023
Business Wire
Press Release: Cyteir : Cyteir Therapeutics Reports First Quarter 2023 Financial Results and Operational Highlights
Cyteir Competitors
1
2
3
4
5
6
7
8
9
10